Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash & Equivalents: 2020-2025

Historic Cash & Equivalents for MDxHealth (MDXH) over the last 6 years, with Sep 2025 value amounting to $32.0 million.

  • MDxHealth's Cash & Equivalents fell 35.03% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year decrease of 35.03%. This contributed to the annual value of $46.8 million for FY2024, which is 109.12% up from last year.
  • Per MDxHealth's latest filing, its Cash & Equivalents stood at $32.0 million for Q3 2025, which was down 2.43% from $32.8 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Cash & Equivalents registered a high of $65.7 million during Q1 2025, and its lowest value of $15.5 million during Q4 2022.
  • In the last 3 years, MDxHealth's Cash & Equivalents had a median value of $36.1 million in 2023 and averaged $38.9 million.
  • As far as peak fluctuations go, MDxHealth's Cash & Equivalents surged by 266.69% in 2021, and later tumbled by 73.50% in 2022.
  • MRQ analysis of 5 years shows MDxHealth's Cash & Equivalents stood at $58.5 million in 2021, then crashed by 73.50% to $15.5 million in 2022, then soared by 44.36% to $22.4 million in 2023, then skyrocketed by 109.12% to $46.8 million in 2024, then tumbled by 31.59% to $32.0 million in 2025.
  • Its Cash & Equivalents stands at $32.0 million for Q3 2025, versus $32.8 million for Q2 2025 and $65.7 million for Q1 2025.